Vinz Klortho

Amgen: Lost in the Biotech Bargain Bin

Two problems with your analysis:

1) Amgen's future revenues will not be as predictable as they have been in the past.

2) P/E ratios for the markets are very high compared to historical levels. Due to the recession and the deflationary credit crisis, P/E ratios are headed down from the 20's to something more like 8-12.

Either way, Amgen is not the screaming buy you imply that it is.

Vinz